These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 6370515)

  • 21. A central role for inducible heat-shock protein 70 in autoimmune vitiligo.
    Mosenson JA; Eby JM; Hernandez C; Le Poole IC
    Exp Dermatol; 2013 Sep; 22(9):566-9. PubMed ID: 23786523
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Dysregulation of melanocyte function by Th17-related cytokines: significance of Th17 cell infiltration in autoimmune vitiligo vulgaris.
    Kotobuki Y; Tanemura A; Yang L; Itoi S; Wataya-Kaneda M; Murota H; Fujimoto M; Serada S; Naka T; Katayama I
    Pigment Cell Melanoma Res; 2012 Mar; 25(2):219-30. PubMed ID: 22136309
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antibodies to normal human melanocytes in vitiligo.
    Naughton GK; Eisinger M; Bystryn JC
    J Exp Med; 1983 Jul; 158(1):246-51. PubMed ID: 6345714
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Vitiligo, autoimmune disease and melanoma.
    James B
    J R Soc Med; 1993 Apr; 86(4):246. PubMed ID: 8369050
    [No Abstract]   [Full Text] [Related]  

  • 25. Aetiology of vitiligo.
    Lancet; 1971 Dec; 2(7737):1298-9. PubMed ID: 4143544
    [No Abstract]   [Full Text] [Related]  

  • 26. Expansion of vitiligo lesions is associated with reduced epidermal CDw60 expression and increased expression of HLA-DR in perilesional skin.
    Le Poole IC; Stennett LS; Bonish BK; Dee L; Robinson JK; Hernandez C; Hann SK; Nickoloff BJ
    Br J Dermatol; 2003 Oct; 149(4):739-48. PubMed ID: 14616364
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Autoimmune diseases affecting skin melanocytes in dogs, cats and horses: vitiligo and the uveodermatological syndrome: a comprehensive review.
    Tham HL; Linder KE; Olivry T
    BMC Vet Res; 2019 Jul; 15(1):251. PubMed ID: 31324191
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Vitiligo and polyglandular autoimmune disease with autoantibodies to melanin-producing cells. A new syndrome?
    Peserico A; Rigon F; Semenzato G; Caretto A; Pasini CV; Betterle C
    Arch Dermatol; 1981 Nov; 117(11):751-2. PubMed ID: 7316541
    [No Abstract]   [Full Text] [Related]  

  • 29. Autoimmune destruction of skin melanocytes by perilesional T cells from vitiligo patients.
    van den Boorn JG; Konijnenberg D; Dellemijn TA; van der Veen JP; Bos JD; Melief CJ; Vyth-Dreese FA; Luiten RM
    J Invest Dermatol; 2009 Sep; 129(9):2220-32. PubMed ID: 19242513
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Vitiligo and Koebner phenomenon following platelet-rich plasma injections].
    Ejjiyar M; Sahibi M; El Gueouatri M; Bhihi A; Mahrouch M; Yafi I; El Amrani MD; Benchamkha Y
    Pan Afr Med J; 2019; 32():58. PubMed ID: 31223350
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Genuine vitiligo and its relevance for internal medicine].
    Höfs T
    Z Gesamte Inn Med; 1980 Apr; 35(7):285-9. PubMed ID: 6996361
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Vitiligo and allergic complications from orthopaedic joint implants: the role of benzoyl peroxide.
    Dudda M; Godau P; Al-Benna S; Schildhauer TA; Gothner M
    Recent Pat Inflamm Allergy Drug Discov; 2013 May; 7(2):176-82. PubMed ID: 23574546
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Complement-fixing activity to melanin-producing cells preceding the onset of vitiligo in a patient with type 1 polyglandular failure.
    Betterle C; Caretto A; Pedini B; Rigon F; Bertoli P; Peserico A
    Arch Dermatol; 1992 Jan; 128(1):123-4. PubMed ID: 1739282
    [No Abstract]   [Full Text] [Related]  

  • 34. Vitiligo. A symptom complex.
    el-Mofty AM; el-Mofty M
    Int J Dermatol; 1980 Jun; 19(5):237-44. PubMed ID: 6993382
    [No Abstract]   [Full Text] [Related]  

  • 35. The significance of depigmentation.
    Nordlund JJ
    Pigment Cell Res; 1992; Suppl 2():237-41. PubMed ID: 1409425
    [No Abstract]   [Full Text] [Related]  

  • 36. Vitiligo.
    Huggins RH; Schwartz RA; Janniger C
    Acta Dermatovenerol Alp Pannonica Adriat; 2005 Dec; 14(4):137-42, 144-5. PubMed ID: 16435042
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Autoimmunity as an aetiological factor in vitiligo.
    Rezaei N; Gavalas NG; Weetman AP; Kemp EH
    J Eur Acad Dermatol Venereol; 2007 Aug; 21(7):865-76. PubMed ID: 17658994
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Vitiligo in autoimmune thyroid disease.
    Shong YK; Kim JA
    Thyroidology; 1991 May; 3(2):89-91. PubMed ID: 1726907
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Vitiligo in an Italian outpatient center: a clinical and serologic study of 204 patients in Tuscany.
    Berti S; Bellandi S; Bertelli A; Colucci R; Lotti T; Moretti S
    Am J Clin Dermatol; 2011 Feb; 12(1):43-9. PubMed ID: 21110525
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Detection of antibodies to melanocytes in vitiligo by western immunoblotting.
    Hann SK; Shin HK; Park SH; Reynolds SR; Bystryn JC
    Yonsei Med J; 1996 Dec; 37(6):365-70. PubMed ID: 9048487
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.